Loading...
XBRU
TUB
Market cap8.53bUSD
Oct 09, Last price  
170.00EUR
1D
0.41%
1Q
-18.50%
Jan 2017
186.58%
Name

Financiere de Tubize SA

Chart & performance

D1W1MN
XBRU:TUB chart
P/E
81.17
P/S
—
EPS
2.09
Div yield, %
0.61%
Shrs. gr., 5y
—
Rev. gr., 5y
27.08%
Revenues
0
-100.00%
0000000001,000302,000004,000008,151013,2570
Net income
93m
+3.47%
477,274,00039,534,000-905,000163,308,00020,868,00064,685,00077,812,00061,706,00060,845,000212,526,000181,186,000285,934,000285,156,000283,704,000260,519,00083,602,31385,169,88888,151,26790,104,32993,228,016
CFO
92m
P
327,964,0005,605,0005,322,000-12,794,000-1,121,000124,000-1,404,000-823,000-613,00063,449,00067,699,00072,962,00075,757,00079,778,00081,138,00084,024,000174,225,312-2,045,999-2,069,00091,843,000
Dividend
Jun 12, 20260.0405 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

Key people

Bruno Holthof
Independent Chairman of the Board · since 2025
Eric Nys
General Manager of Day To Day Management - Representative of ENRE SRL · since 2022
Eric Cornut
Director · since 2023
Evelyn Diego Du Monceau De Bergendal
Director · since 2015
Tanguy du Monceau
Director - Representative of Bergendal and Co SRL · since 2024
Fiona du Monceau
Director · since 2023
Cynthia Favre D'Echallens
Director · since 2014
Cyril Janssen
Director - Representative of Nikita SRL · since 2021
Charles-Antoine Janssen
Director - Representative of BLTB SR · since 2022
Cedric Van Rijckevorsel
Director - Representative of AlgoScient SARL · since 2024
Sandrine Flory
Independent Director · since 2024
URL
http://www.financiere-tubize.be/
IPO date
Jan 02, 1987
Employees
Domiciled in
BE
Incorporated in
BE
Headquarters & legal address
PLACE DU CHAMP DE MARS 5
IXELLES, BRU 1050
BE
Previous name
FINANCIERE DE TUBIZE SA

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT